Literature DB >> 23326172

Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Ana Paula Oppenheimer1, Christopher Koh, Mary McLaughlin, John C Williamson, Thomas D Norton, Jennifer Laudadio, Theo Heller, David E Kleiner, Kevin P High, Caryn G Morse.   

Abstract

Vanishing bile duct syndrome (VBDS) is a group of rare disorders characterized by ductopenia, the progressive destruction and disappearance of intrahepatic bile ducts leading to cholestasis. Described in association with medications, autoimmune disorders, cancer, transplantation, and infections, the specific mechanisms of disease are not known. To date, only 4 cases of VBDS have been reported in human immunodeficiency virus (HIV) infected patients. We report 2 additional cases of HIV-associated VBDS and review the features common to the HIV-associated cases. Presentation includes hyperbilirubinemia, normal liver imaging, and negative viral and autoimmune hepatitis studies. In HIV-infected subjects, VBDS occurred at a range of CD4+ T-cell counts, in some cases following initiation or change in antiretroviral therapy. Lymphoma was associated with two cases; nevirapine, antibiotics, and viral co-infection were suggested as etiologies in the other cases. In HIV-positive patients with progressive cholestasis, early identification of VBDS and referral for transplantation may improve outcomes.

Entities:  

Keywords:  Antiretroviral therapy; Ductopenia; Human immunodeficiency virus; Liver biopsy; Vanishing bile duct syndrome

Mesh:

Substances:

Year:  2013        PMID: 23326172      PMCID: PMC3542762          DOI: 10.3748/wjg.v19.i1.115

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.

Authors:  B van Hoek; R H Wiesner; J Ludwig; C Paya
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases.

Authors:  S G Hubscher; J A Buckels; E Elias; P McMaster; J M Neuberger
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Liver findings in infantile cytomegalovirus infection: similarity to extrahepatic biliary obstruction.

Authors:  M Lurie; I Elmalach; L Schuger; Z Weintraub
Journal:  Histopathology       Date:  1987-11       Impact factor: 5.087

4.  Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis.

Authors:  J Ludwig; R H Wiesner; N F LaRusso
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

5.  Vanishing bile duct syndrome associated with chronic EBV infection.

Authors:  K Kikuchi; H Miyakawa; K Abe; H Fujikawa; T Horiuchi; K Nagai; M Kako
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

6.  Severe pancreatitis in an AIDS patient in association with cytomegalovirus infection.

Authors:  L Joe; A F Ansher; F M Gordin
Journal:  South Med J       Date:  1989-11       Impact factor: 0.954

7.  Intrahepatic expression of hepatitis C virus antigens in chronic liver disease.

Authors:  K T Nouri-Aria; R Sallie; M Mizokami; B C Portmann; R Williams
Journal:  J Pathol       Date:  1995-01       Impact factor: 7.996

8.  Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome.

Authors:  J C Arnold; B C Portmann; J G O'Grady; N V Naoumov; G J Alexander; R Williams
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

9.  Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia.

Authors:  C Degott; G Feldmann; D Larrey; A M Durand-Schneider; D Grange; J P Machayekhi; A Moreau; F Potet; J P Benhamou
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

10.  Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.

Authors:  S G Hubscher; M A Lumley; E Elias
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

View more
  1 in total

1.  Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective.

Authors:  Sarah Chwiki; Maria Mercedes Campos; Mary E McLaughlin; David E Kleiner; Joseph A Kovacs; Caryn G Morse; Mones S Abu-Asab
Journal:  Ultrastruct Pathol       Date:  2017-02-28       Impact factor: 1.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.